Cite

HARVARD Citation

    Brat, K. et al. (2020). Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry. Thoracic cancer. 11 (11), pp. 3346-3356. [Online]. 
  
Back to record